Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07608861Recruiting
Trial of bupivacaine and lidocaine in pain (2 arms), sponsored by Atatürk Chest Diseases and Chest Surgery Training and Research Hospital. Primary endpoint: Intraoperative remifentanil consumption. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07608861.